{"id":1978,"date":"2026-05-11T12:00:06","date_gmt":"2026-05-11T12:00:06","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/05\/11\/in-landmark-approval-fda-oks-ocrevus-for-kids-10-and-older-with-rrms\/"},"modified":"2026-05-11T12:00:06","modified_gmt":"2026-05-11T12:00:06","slug":"in-landmark-approval-fda-oks-ocrevus-for-kids-10-and-older-with-rrms","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/05\/11\/in-landmark-approval-fda-oks-ocrevus-for-kids-10-and-older-with-rrms\/","title":{"rendered":"In \u2018landmark\u2019 approval, FDA OKs Ocrevus for kids 10 and older with RRMS"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/05\/11\/fda-approves-ocrevus-treating-children-10-older-relapsing-remitting-ms\/\" title=\"In &#8216;landmark&#8217; approval, FDA OKs Ocrevus for kids 10 and older with RRMS\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"534\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2026\/05\/iStock-2209135050-800x534.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"An adult holds the bandaged hand of a child in a hospital bed receiving an infusion, while the youngster clutches a teddy bear with the other hand.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"162035\" \/><\/a><\/p>\n<p>The U.S. Food and Drug Administration (FDA) has approved the infusion therapy Ocrevus (ocrelizumab) for treating children with relapsing-remitting multiple sclerosis (RRMS) who are ages 10 and older and weigh at least 55 pounds (25 kg). The approval makes Ocrevus the second-ever therapy to win formal FDA approval for this indication, according to its developer [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/05\/11\/fda-approves-ocrevus-treating-children-10-older-relapsing-remitting-ms\/\">In &#8216;landmark&#8217; approval, FDA OKs Ocrevus for kids 10 and older with RRMS<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/05\/11\/fda-approves-ocrevus-treating-children-10-older-relapsing-remitting-ms\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The U.S. Food and Drug Administration (FDA) has approved the infusion therapy Ocrevus (ocrelizumab) for treating children with relapsing-remitting multiple sclerosis (RRMS) who are ages 10 and older and weigh at least 55 pounds (25 kg). The approval makes Ocrevus the second-ever therapy to win&hellip;<\/p>\n","protected":false},"author":0,"featured_media":1979,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1978","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1978","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1978"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1978\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1979"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1978"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1978"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1978"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}